77.4 F
New York
Thursday, July 29, 2021

Charles River Laboratories [NYSE: CRL] To Purchase Cognate Bioservices For $875

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Charles River Laboratories International, Inc. [NYSE: CRL] revealed that the company has entered into a contract to purchase Cognate BioServices, Inc. for around $875 million in cash. The transaction is subject to customary closing conditions.  

James C. Cultivate, CEO of CRL, stated, “Cognate BioServices presents a novel chance to venture into a high-development, value-added area of the CDMO market. Moreover, It aids us to improve our capacity to address our customers’ needs in arising regions of scientific advancement.”

He further added,” This purchase will be an outstanding key fit, adding to our thorough set-up of early-phase study. It will aid in producing support solutions and empowering us to accomplish our objective of building up a solitary scientific partner to furnish biopharmaceutical customers. So that we can provide clients with an incorporated solution to aid enhancing their cell and gene treatment programs.”

Cognate is a cell and gene therapy CDMo that offers a variety of cell therapy solutions. The transaction will create CRL as a sole partner for cell and gene treatment. Furthermore, CRL will be able to provide the customers with integrated solutions from basic research through GCMP creation. Cognate has broad experience creating different cell types and advances utilized in cell immunotherapy and immuno-oncology.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...